EURJMEDRES . BIOMEDCENTRAL . COM {
}
Title:
Bile pigments in emergency and critical care medicine | European Journal of Medical Research | Full Text
Description:
Bile pigments, such as bilirubin and biliverdin, are end products of the heme degradation pathway in mammals and are widely known for their cytotoxic effects. However, recent studies have revealed that they exert cytoprotective effects through antioxidative, anti-inflammatory, and immunosuppressive properties. All these mechanisms are indispensable in the treatment of diseases in the field of emergency and critical care medicine, such as coronary ischemia, stroke, encephalomyelitis, acute lung injury/acute respiratory distress syndrome, mesenteric ischemia, and sepsis. While further research is required before the safe application of bile pigments in the clinical setting, their underlying mechanisms shed light on their utilization as therapeutic agents in the field of emergency and critical care medicine. This article aims to summarize the current understanding of bile pigments and re-evaluate their therapeutic potential in the diseases listed above.
Website Age:
25 years and 10 months (reg. 1999-08-06).
Matching Content Categories {π}
- Insurance
- Social Networks
- Science
Content Management System {π}
What CMS is eurjmedres.biomedcentral.com built with?
Custom-built
No common CMS systems were detected on Eurjmedres.biomedcentral.com, and no known web development framework was identified.
Traffic Estimate {π}
What is the average monthly size of eurjmedres.biomedcentral.com audience?
π Good Traffic: 50k - 100k visitors per month
Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Eurjmedres.biomedcentral.com Make Money? {πΈ}
Display Ads {π―}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (3)
yourbow.com, google.com, doceree.comHow Much Does Eurjmedres.biomedcentral.com Make? {π°}
Display Ads {π―}
$690 per month
Estimations show Eurjmedres.biomedcentral.com's display ad online revenue falls between $462 and $1,271 per month.
Keywords {π}
cookies, bmc, privacy, cell, page, data, european, encephalomyelitis, essential, optional, content, personal, parties, policy, information, manage, journal, medical, research, bile, pigments, mechanisms, reactivity, nfΞΊb, activation, ros, article, contact, editing, authors, choice, make, site, function, advertising, personalisation, usage, analysis, social, media, accepting, consent, processing, including, transfers, economic, area, varying, standards, protection,
Topics {βοΈ}
authors scientific editing privacy choices/manage cookies bmc 2047-783x contact account european journal european economic area medical research home nuclear factor kappa reactive oxygen species state privacy rights accepting optional cookies br inhibits stat-1 nf-ΞΊb activation manage preferences bile pigments personal data optional cookies nf-ΞΊb data protection cookies skip cell activation cookies policy privacy policy privacy statement essential cookies usage analysis social media varying standards br acts important immunomodulator cell reactivity iΞΊb phosphorylation therapeutic agent helper cell general enquiries preference centre springer nature content multiple mechanisms choices privacy br essential mechanisms choice make site function advertising personalisation
Schema {πΊοΈ}
WebPage:
mainEntity:
headline:Bile pigments in emergency and critical care medicine
description:Bile pigments, such as bilirubin and biliverdin, are end products of the heme degradation pathway in mammals and are widely known for their cytotoxic effects. However, recent studies have revealed that they exert cytoprotective effects through antioxidative, anti-inflammatory, and immunosuppressive properties. All these mechanisms are indispensable in the treatment of diseases in the field of emergency and critical care medicine, such as coronary ischemia, stroke, encephalomyelitis, acute lung injury/acute respiratory distress syndrome, mesenteric ischemia, and sepsis. While further research is required before the safe application of bile pigments in the clinical setting, their underlying mechanisms shed light on their utilization as therapeutic agents in the field of emergency and critical care medicine. This article aims to summarize the current understanding of bile pigments and re-evaluate their therapeutic potential in the diseases listed above.
datePublished:2022-10-29T00:00:00Z
dateModified:2022-10-29T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s40001-022-00863-0
keywords:
Bile pigments
Emergency and critical care medicine
Antioxidant therapy
Medicine/Public Health
general
Infectious Diseases
Internal Medicine
Surgery
Oncology
Biomedicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig4_HTML.png
isPartOf:
name:European Journal of Medical Research
issn:
2047-783X
volumeNumber:27
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Mizuki Seya
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
type:Person
name:Toshiyuki Aokage
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Tsuyoshi Nojima
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
type:Person
name:Atsunori Nakao
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiromichi Naito
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Bile pigments in emergency and critical care medicine
description:Bile pigments, such as bilirubin and biliverdin, are end products of the heme degradation pathway in mammals and are widely known for their cytotoxic effects. However, recent studies have revealed that they exert cytoprotective effects through antioxidative, anti-inflammatory, and immunosuppressive properties. All these mechanisms are indispensable in the treatment of diseases in the field of emergency and critical care medicine, such as coronary ischemia, stroke, encephalomyelitis, acute lung injury/acute respiratory distress syndrome, mesenteric ischemia, and sepsis. While further research is required before the safe application of bile pigments in the clinical setting, their underlying mechanisms shed light on their utilization as therapeutic agents in the field of emergency and critical care medicine. This article aims to summarize the current understanding of bile pigments and re-evaluate their therapeutic potential in the diseases listed above.
datePublished:2022-10-29T00:00:00Z
dateModified:2022-10-29T00:00:00Z
pageStart:1
pageEnd:11
license:http://creativecommons.org/publicdomain/zero/1.0/
sameAs:https://doi.org/10.1186/s40001-022-00863-0
keywords:
Bile pigments
Emergency and critical care medicine
Antioxidant therapy
Medicine/Public Health
general
Infectious Diseases
Internal Medicine
Surgery
Oncology
Biomedicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40001-022-00863-0/MediaObjects/40001_2022_863_Fig4_HTML.png
isPartOf:
name:European Journal of Medical Research
issn:
2047-783X
volumeNumber:27
type:
Periodical
PublicationVolume
publisher:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Mizuki Seya
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
type:Person
name:Toshiyuki Aokage
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Tsuyoshi Nojima
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
type:Person
name:Atsunori Nakao
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
type:Person
name:Hiromichi Naito
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:European Journal of Medical Research
issn:
2047-783X
volumeNumber:27
Organization:
name:BioMed Central
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Mizuki Seya
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
name:Toshiyuki Aokage
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
email:[email protected]
name:Tsuyoshi Nojima
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
name:Atsunori Nakao
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
name:Hiromichi Naito
affiliation:
name:Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
address:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
type:PostalAddress
type:Organization
PostalAddress:
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
name:Department of Emergency, Critical Care, and Disaster Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
External Links {π}(21)
- What are the total earnings of https://www.biomedcentral.com/privacy-statement?
- https://www.biomedcentral.com's total income per month
- What's https://www.biomedcentral.com/journals's gross income?
- Earnings of https://www.biomedcentral.com/getpublished
- What's the monthly income of https://www.biomedcentral.com/about?
- How much does https://www.biomedcentral.com/account generate monthly?
- Revenue of https://submission.nature.com/new-submission/40001/3
- Monthly income for https://blogs.biomedcentral.com/
- Financial intake of https://www.biomedcentral.com/login
- What's the income generated by https://authorservices.springernature.com/go/sn/?utm_source=Website&utm_medium=BMC&utm_campaign=SNAS+Referrals+2022&utm_id=ref2022 each month?
- https://www.biomedcentral.com/about/policies income
- Income figures for https://www.biomedcentral.com/accessibility
- How much money does https://www.biomedcentral.com/about/press-centre make?
- How much profit does https://support.biomedcentral.com/support/home generate?
- What are the earnings of https://biomedcentral.typeform.com/to/VLXboo?
- Find out how much https://www.biomedcentral.com/about/jobs earns monthly
- How much money does http://www.weibo.com/biomedcentral generate?
- Learn about the earnings of https://www.biomedcentral.com/terms-and-conditions
- What's the monthly income of https://www.springernature.com/ccpa?
- How much does https://www.biomedcentral.com/cookies pull in monthly?
- How profitable is https://www.springernature.com?
Analytics and Tracking {π}
- Google Tag Manager
Libraries {π}
- Prism.js
CDN Services {π¦}
- Crossref